Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on AZD0585 PK in Healthy Japanese Males
NCT02372344Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia (3 arms), sponsored by AstraZeneca. Primary endpoints: Area Under the Curve, Maximum Plasma Concentration and 1 more. Started Mar 2015; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT02372344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02372344.